Clinical Trial Update: A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

Climb Bio, Inc. announced a Phase 1b clinical trial evaluating Budoprutug in adults with systemic lupus erythematosus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Budoprutug (Budoprutug)

Snippet

Sponsor: Climb Bio, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING